Nitrosative stress elicited by nNOSμ delocalization inhibits muscle force in dystrophin-null mice

Journal of Pathology

Volumn 223, Issue 1, 2011, Pages 88-98

  Li, Dejia ^a   Yue, Yongping ^a   Lai, Yi ^a   Hakim, Chady H ^a   Duan, Dongsheng ^a  

^a UNIVERSITY OF MISSOURI   (United States)

Author keywords

sarcoglycan; Duchenne muscular dystrophy; dystrophin; mdx; mdx4cv; nitrosative stress; nitrotyrosination; nNOS; ryanodine receptor 1; S nitrosylation

Indexed keywords

CALCIUM; DELTA SARCOGLYCAN; DYSTROPHIN; NEURONAL NITRIC OXIDE SYNTHASE; NEURONAL NITRIC OXIDE SYNTHASE MU; REACTIVE NITROGEN SPECIES; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CALCIUM CELL LEVEL; CONTROLLED STUDY; CYTOSOL; DUCHENNE MUSCULAR DYSTROPHY; GENE SILENCING; KNOCKOUT MOUSE; LIMB GIRDLE MUSCULAR DYSTROPHY; MALE; MOUSE; MUSCLE FORCE; NITROSATIVE STRESS; NONHUMAN; PRIORITY JOURNAL; PROTEIN LOCALIZATION; SARCOLEMMA;

ANIMALS; DYSTROPHIN; MALE; MICE; MICE, INBRED MDX; MICE, KNOCKOUT; MUSCLE CONTRACTION; MUSCLE, SKELETAL; MUSCULAR DYSTROPHIES, LIMB-GIRDLE; MUSCULAR DYSTROPHY, ANIMAL; MUSCULAR DYSTROPHY, DUCHENNE; NITRIC OXIDE SYNTHASE TYPE I; OXIDATIVE STRESS; SARCOGLYCANS; SARCOLEMMA;

EID: 78650021686     PISSN: 00223417     EISSN: 10969896     Source Type: Journal    
DOI: 10.1002/path.2799     Document Type: Article

References (69)

1. Kunkel LM,. 2004 William Allan Award address. Cloning of the DMD gene. Am J Hum Genet 2005; 76: 205-214.
2. Petrof BJ, Shrager JB, Stedman HH, et al., Dystrophin protects the sarcolemma from stresses developed during muscle contraction. Proc Natl Acad Sci U S A 1993; 90: 3710-3714.
3. Rando TA,. Role of nitric oxide in the pathogenesis of muscular dystrophies: a 'two hit' hypothesis of the cause of muscle necrosis. Microsc Res Tech 2001; 55: 223-235.
4. Lai Y, Thomas GD, Yue Y, et al., Dystrophins carrying spectrin-like repeats 16 and 17 anchor nNOS to the sarcolemma and enhance exercise performance in a mouse model of muscular dystrophy. J Clin Invest 2009; 119: 624-635.
5. Brenman JE, Chao DS, Xia H, et al., Nitric oxide synthase complexed with dystrophin and absent from skeletal muscle sarcolemma in Duchenne muscular dystrophy. Cell 1995; 82: 743-752.
6. Chao DS, Gorospe JR, Brenman JE, et al., Selective loss of sarcolemmal nitric oxide synthase in Becker muscular dystrophy. J Exp Med 1996; 184: 609-618.
7. Chang WJ, Iannaccone ST, Lau KS, et al., Neuronal nitric oxide synthase and dystrophin-deficient muscular dystrophy. Proc Natl Acad Sci U S A 1996; 93: 9142-9147.
8. Kameya S, Miyagoe Y, Nonaka I, et al., Alpha1-syntrophin gene disruption results in the absence of neuronal-type nitric-oxide synthase at the sarcolemma but does not induce muscle degeneration. J Biol Chem 1999; 274: 2193-2200.
9. Crosbie RH, Straub V, Yun HY, et al., mdx muscle pathology is independent of nNOS perturbation. Hum Mol Genet 1998; 7: 823-829.
10. Thomas GD, Sander M, Lau KS, et al., Impaired metabolic modulation of alpha-adrenergic vasoconstriction in dystrophin-deficient skeletal muscle. Proc Natl Acad Sci U S A 1998; 95: 15090-15095.
11. Torelli S, Brown SC, Jimenez-Mallebrera C, et al., Absence of neuronal nitric oxide synthase (nNOS) as a pathological marker for the diagnosis of Becker muscular dystrophy with rod domain deletions. Neuropathol Appl Neurobiol 2004; 30: 540-545.
12. Wells KE, Torelli S, Lu Q, et al., Relocalization of neuronal nitric oxide synthase (nNOS) as a marker for complete restoration of the dystrophin associated protein complex in skeletal muscle. Neuromuscul Disord 2003; 13: 21-31.
13. Stamler JS, Meissner G,. Physiology of nitric oxide in skeletal muscle. Physiol Rev 2001; 81: 209-237.
14. Murrant CL, Reid MB,. Detection of reactive oxygen and reactive nitrogen species in skeletal muscle. Microsc Res Tech 2001; 55: 236-248.
15. Jackson MJ, Pye D, Palomero J,. The production of reactive oxygen and nitrogen species by skeletal muscle. J Appl Physiol 2007; 102: 1664-1670.
16. Chapman VM, Miller DR, Armstrong D, et al., Recovery of induced mutations for X chromosome-linked muscular dystrophy in mice. Proc Natl Acad Sci U S A 1989; 86: 1292-1296.
17. Huang PL, Dawson TM, Bredt DS, et al., Targeted disruption of the neuronal nitric oxide synthase gene. Cell 1993; 75: 1273-1286.
18. Chao DS, Silvagno F, Bredt DS,. Muscular dystrophy in mdx mice despite lack of neuronal nitric oxide synthase. J Neurochem 1998; 71: 784-789.
19. Li D, Long C, Yue Y, et al., Sub-physiological sarcoglycan expression contributes to compensatory muscle protection in mdx mice. Hum Mol Genet 2009; 18: 1209-1220.
20. Harper SQ, Hauser MA, DelloRusso C, et al., Modular flexibility of dystrophin: implications for gene therapy of Duchenne muscular dystrophy. Nature Med 2002; 8: 253-261.
21. Ervasti JM, Campbell KP,. Membrane organization of the dystrophin-glycoprotein complex. Cell 1991; 66: 1121-1131.
22. Li D, Yue Y, Duan D,. Preservation of muscle force in mdx3cv mice correlates with low-level expression of a near full-length dystrophin protein. Am J Pathol 2008; 172: 1332-1341.
23. Saito A, Seiler S, Chu A, et al., Preparation and morphology of sarcoplasmic reticulum terminal cisternae from rabbit skeletal muscle. J Cell Biol 1984; 99: 875-885.
24. Forrester MT, Thompson JW, Foster MW, et al., Proteomic analysis of S-nitrosylation and denitrosylation by resin-assisted capture. Nature Biotechnol 2009; 27: 557-559.
25. Liu M, Yue Y, Harper SQ, et al., Adeno-associated virus-mediated microdystrophin expression protects young mdx muscle from contraction-induced injury. Mol Ther 2005; 11: 245-256.
26. Dellorusso C, Crawford RW, Chamberlain JS, et al., Tibialis anterior muscles in mdx mice are highly susceptible to contraction-induced injury. J Muscle Res Cell Motil 2001; 22: 467-475.
27. Mendez J, Keys A,. Density and composition of mammalian muscle. Metabolism 1960; 9: 184-188.
28. Burkholder TJ, Fingado B, Baron S, et al., Relationship between muscle fiber types and sizes and muscle architectural properties in the mouse hindlimb. J Morphol 1994; 221: 177-190.
29. Brooks SV, Faulkner JA,. Contractile properties of skeletal muscles from young, adult and aged mice. J Physiol 1988; 404: 71-82.
30. Powers SK, Jackson MJ,. Exercise-induced oxidative stress: cellular mechanisms and impact on muscle force production. Physiol Rev 2008; 88: 1243-1276.
31. Dudley RW, Danialou G, Govindaraju K, et al., Sarcolemmal damage in dystrophin deficiency is modulated by synergistic interactions between mechanical and oxidative/nitrosative stresses. Am J Pathol 2006; 168: 1276-1287.
32. Dudley RW, Khairallah M, Mohammed S, et al., Dynamic responses of the glutathione system to acute oxidative stress in dystrophic mouse (mdx) muscles. Am J Physiol Regul Integr Comp Physiol 2006; 291: R704-R710.
33. Bellinger AM, Reiken S, Carlson C, et al., Hypernitrosylated ryanodine receptor calcium release channels are leaky in dystrophic muscle. Nature Med 2009; 15: 325-330.
34. Bredt DS,. Endogenous nitric oxide synthesis: biological functions and pathophysiology. Free Radic Res 1999; 31: 577-596.
35. Percival JM, Anderson KN, Huang P, et al., Golgi and sarcolemmal neuronal NOS differentially regulate contraction-induced fatigue and vasoconstriction in exercising mouse skeletal muscle. J Clin Invest 2010; 120: 816-826.
36. Tochio H, Zhang Q, Mandal P, et al., Solution structure of the extended neuronal nitric oxide synthase PDZ domain complexed with an associated peptide. Nature Struct Biol 1999; 6: 417-421.
37. Hillier BJ, Christopherson KS, Prehoda KE, et al., Unexpected modes of PDZ domain scaffolding revealed by structure of nNOS-syntrophin complex. Science 1999; 284: 812-815.
38. Sander M, Chavoshan B, Harris SA, et al., Functional muscle ischemia in neuronal nitric oxide synthase-deficient skeletal muscle of children with Duchenne muscular dystrophy. Proc Natl Acad Sci U S A 2000; 97: 13818-13823.
39. Percival JM, Anderson KN, Gregorevic P, et al., Functional deficits in nNOSmu-deficient skeletal muscle: myopathy in nNOS knockout mice. PLoS ONE 2008; 3: e3387.
40. Kobayashi YM, Rader EP, Crawford RW, et al., Sarcolemma-localized nNOS is required to maintain activity after mild exercise. Nature 2008; 456: 511-515.
41. Colussi C, Gurtner A, Rosati J, et al., Nitric oxide deficiency determines global chromatin changes in Duchenne muscular dystrophy. FASEB J 2009; 23: 2131-2141.
42. Colussi C, Mozzetta C, Gurtner A, et al., HDAC2 blockade by nitric oxide and histone deacetylase inhibitors reveals a common target in Duchenne muscular dystrophy treatment. Proc Natl Acad Sci U S A 2008; 105: 19183-19187.
43. Filippin LI, Moreira AJ, Marroni NP, et al., Nitric oxide and repair of skeletal muscle injury. Nitric Oxide 2009; 21: 157-163.
44. Anderson JE,. A role for nitric oxide in muscle repair: nitric oxide-mediated activation of muscle satellite cells. Mol Biol Cell 2000; 11: 1859-1874.
45. Archer JD, Vargas CC, Anderson JE,. Persistent and improved functional gain in mdx dystrophic mice after treatment with L -arginine and deflazacort. FASEB J 2006; 20: 738-740.
46. Hnia K, Gayraud J, Hugon G, et al., L -arginine decreases inflammation and modulates the nuclear factor-kappaB/matrix metalloproteinase cascade in mdx muscle fibers. Am J Pathol 2008; 172: 1509-1519.
47. Brunelli S, Sciorati C, D'Antona G, et al., Nitric oxide release combined with nonsteroidal antiinflammatory activity prevents muscular dystrophy pathology and enhances stem cell therapy. Proc Natl Acad Sci U S A 2007; 104: 264-269.
48. Voisin V, Sebrie C, Matecki S, et al., L -arginine improves dystrophic phenotype in mdx mice. Neurobiol Dis 2005; 20: 123-130.
49. Wehling M, Spencer MJ, Tidball JG,. A nitric oxide synthase transgene ameliorates muscular dystrophy in mdx mice. J Cell Biol 2001; 155: 123-132.
50. Kobzik L, Reid MB, Bredt DS, et al., Nitric oxide in skeletal muscle. Nature 1994; 372: 546-548.
51. Eu JP, Hare JM, Hess DT, et al., Concerted regulation of skeletal muscle contractility by oxygen tension and endogenous nitric oxide. Proc Natl Acad Sci U S A 2003; 100: 15229-15234.
52. Bellinger AM, Mongillo M, Marks AR,. Stressed out: the skeletal muscle ryanodine receptor as a target of stress. J Clin Invest 2008; 118: 445-453.
53. Durham WJ, Aracena-Parks P, Long C, et al., RyR1 S-nitrosylation underlies environmental heat stroke and sudden death in Y522S RyR1 knockin mice. Cell 2008; 133: 53-65.
54. Bellinger AM, Reiken S, Dura M, et al., Remodeling of ryanodine receptor complex causes 'leaky' channels: a molecular mechanism for decreased exercise capacity. Proc Natl Acad Sci U S A 2008; 105: 2198-2202.
55. Sunada Y, Ohi H, Hase A, et al., Transgenic mice expressing mutant caveolin-3 show severe myopathy associated with increased nNOS activity. Hum Mol Genet 2001; 10: 173-178.
56. Wehling-Henricks M, Jordan MC, Gotoh T, et al., Arginine metabolism by macrophages promotes cardiac and muscle fibrosis in mdx muscular dystrophy. PLoS ONE 2010; 5: e10763.
57. Hack AA, Lam MY, Cordier L, et al., Differential requirement for individual sarcoglycans and dystrophin in the assembly and function of the dystrophin-glycoprotein complex. J Cell Sci 2000; 113: 2535-2544.
58. Nakamura TY, Iwata Y, Sampaolesi M, et al., Stretch-activated cation channels in skeletal muscle myotubes from sarcoglycan-deficient hamsters. Am J Physiol Cell Physiol 2001; 281: C690-C699.
59. Sampaolesi M, Yoshida T, Iwata Y, et al., Stretch-induced cell damage in sarcoglycan-deficient myotubes. Pflugers Arch 2001; 442: 161-170.
60. 2+ homeostasis and cell damage in myopathic skeletal muscle cells. Biochem Pharmacol 2005; 70: 740-751.
61. 2+ transients in delta-sarcoglycan knockout mouse skeletal muscle. Biochim Biophys Acta 2010; 1800: 373-379.
62. Bogdanovich S, McNally EM, Khurana TS,. Myostatin blockade improves function but not histopathology in a murine model of limb-girdle muscular dystrophy 2C. Muscle Nerve 2008; 37: 308-316.
63. Hack AA, Cordier L, Shoturma DI, et al., Muscle degeneration without mechanical injury in sarcoglycan deficiency. Proc Natl Acad Sci U S A 1999; 96: 10723-10728.
64. Hopf FW, Turner PR, Steinhardt RA,. Calcium misregulation and the pathogenesis of muscular dystrophy. Subcell Biochem 2007; 45: 429-464.
65. Turner PR, Westwood T, Regen CM, et al., Increased protein degradation results from elevated free calcium levels found in muscle from mdx mice. Nature 1988; 335: 735-738.
66. Friedrich O, Both M, Gillis JM, et al., Mini-dystrophin restores L-type calcium currents in skeletal muscle of transgenic mdx mice. J Physiol 2004; 555: 251-265.
67. Marchand E, Constantin B, Balghi H, et al., Improvement of calcium handling and changes in calcium-release properties after mini- or full-length dystrophin forced expression in cultured skeletal myotubes. Exp Cell Res 2004; 297: 363-379.
68. Balghi H, Sebille S, Mondin L, et al., Mini-dystrophin expression down-regulates IP3-mediated calcium release events in resting dystrophin-deficient muscle cells. J Gen Physiol 2006; 128: 219-230. (Pubitemid 44156759)
69. Teichmann MD, Wegner FV, Fink RH, et al., Inhibitory control over Ca(2 +) sparks via mechanosensitive channels is disrupted in dystrophin deficient muscle but restored by mini-dystrophin expression. PLoS ONE 2008; 3: e3644.